A discussion on the role of biologics in orthopedics

Josh SandbergOctober 8, 2014

1,652 Less than a minute

PHILADELPHIA — At the Impact of Sports 2014 Summit, Nicola Maffulli, MD, MS, PhD, FRCS(Orth), offers his insight on the role of biologics (stem cells, PRP, etc.) in the management of orthopedic conditions.

<br />

Josh Sandberg

Josh Sandberg is the President and CEO of Ortho Spine Partners and sits on several company and industry related Boards. He also is the Creator and Editor of OrthoSpineNews.

A discussion on the role of biologics in orthopedics

Josh Sandberg

New Study from HSS Reveals Minimally Invasive Procedure Can Delay Arthritis in Select Patients with Hip Impingement

Four mega mergers helped increase M&A in Q1

Sports Medicine Market Global Forecast 2024-2030, Featuring Key Players Zimmer Biomet, Medtronic, Smith & Nephew, Stryker, Novartis, Johnson & Johnson, Conmed and Surgalign Holdings.

Josh Sandberg

Related Articles

Orthofix Names Andres Cedron as New Chief Legal Officer

Theradaptive Strengthens Executive Team with Hire of Frank Vizesi as Chief Scientific Officer

FibroBiologics Granted Patent for Regeneration of Cartilage-Type Cells by the Australian Patent Office

Alafair Biosciences Receives Innovative Technology Contract from Vizient for VersaWrap®

New Study from HSS Reveals Minimally Invasive Procedure Can Delay Arthritis in Select Patients with Hip Impingement

Four mega mergers helped increase M&A in Q1

Sports Medicine Market Global Forecast 2024-2030, Featuring Key Players Zimmer Biomet, Medtronic, Smith & Nephew, Stryker, Novartis, Johnson & Johnson, Conmed and Surgalign Holdings.